New app aims to bridge depression care gap for MS patients

NCT ID NCT05865405

Ongoing Symptom relief Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests a smartphone app called MS CATCH that lets people with multiple sclerosis regularly report their mood to their neurologist. The goal is to improve how doctors screen and treat depression in MS. About 100 adults with MS and mild-to-moderate depression are taking part.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MS CATCH smartphone application (behavioral intervention)
What this could lead to: If it works, this could point toward a simple, scalable way to catch and treat depression earlier in people with multiple sclerosis.
What could go wrong: This is a small, early-stage study testing a tool, not a treatment. It may not improve depression outcomes or be practical in routine care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Consciousness Disorders Depression depressive disorder multiple sclerosis myeloid sarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEPRESSION MS MULTIPLE SCLEROSIS

Contacts and locations

Locations

Weill Institute for Neurosciences, University of California, San Francisco

San Francisco, California, 94158, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.